More Business Wire

View Older Stories View Newer Stories

Apr 3, 2025 08:05AM Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada
Apr 3, 2025 08:05AM o9 Goes Live at Prada Group with Advanced Production and Procurement Planning Capabilities
Apr 3, 2025 08:05AM Rezolve Ai Joins B2B Online to Host Webinar on Mastering B2B Site Search for Growth
Apr 3, 2025 08:05AM Alliant Insurance Services Celebrates 100-Year Legacy, Elevates its Position as the Leading Specialty Broker at RIMS® RISKWORLD® in Chicago
Apr 3, 2025 08:05AM LogProstyle Inc. Establishes Subsidiary "LogProstyle US Inc." in Nevada, USA
Apr 3, 2025 08:05AM FireMon Honored with Placement in the 2025 CRN® Partner Program Guide
Apr 3, 2025 08:05AM Boyd Opens State of the Art Battery Material Test Lab to Safely Accelerate Battery Design and New Product Introduction
Apr 3, 2025 08:05AM Boltive Leads the Way With New Digital Compliance Software Suite
Apr 3, 2025 08:05AM Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors
Apr 3, 2025 08:02AM SmartBear Launches Unified Zephyr Platform at Atlassian Team ’25
Apr 3, 2025 08:00AM Cadrenal Therapeutics Participates in Key Medical and Business Development Conferences
Apr 3, 2025 08:00AM GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication
Apr 3, 2025 08:00AM Hidalgo County Criminal District Attorney’s Office Digitally Transforms Evidence Management with NICE Justice
Apr 3, 2025 08:00AM Nimble Introduces New Email Marketing and Template Editor Feature to Power Scalable Campaigns and Outreach
Apr 3, 2025 08:00AM Keynote Speakers Announced for ReSource Pro’s Summit 2025
Apr 3, 2025 08:00AM Redfin Reports Spring Brings Record-High Monthly Housing Costs, Keeping Pending Home Sales at Bay
Apr 3, 2025 08:00AM Epicrispr Biotechnologies Announces FDA Clearance of IND Application for EPI-321, A First-in-Class Epigenetic Therapy for FSHD
Apr 3, 2025 08:00AM Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease
Apr 3, 2025 08:00AM Ontrak Secures Medicaid Provider Designation in Two New States, Enhancing Direct Service Delivery Capabilities
Apr 3, 2025 08:00AM IDIQ Report Reveals Staggering Surge in Fraud and Emerging AI Scam Tactics
Apr 3, 2025 08:00AM Datavault AI to Participate at the LD Micro Invitational XV
Apr 3, 2025 08:00AM SGGG & Mako Fintech Team Up to Streamline Asset Management Onboarding
Apr 3, 2025 08:00AM WisdomTree Launches Core Laddered and High Income Laddered Municipal ETFs
Apr 3, 2025 08:00AM EFG Companies Wins Again: Two Nifty 50 Wins That Drive Powersports F&I Revenue
Apr 3, 2025 08:00AM Balance Launches Balance Settlements
Apr 3, 2025 08:00AM CrowdStrike Appoints Alex Ionescu as Chief Technology Innovation Officer
Apr 3, 2025 08:00AM Versa Next-Generation Firewall Achieves Recommended Rating and 99.90% Security Effectiveness Score in Cloud Network Firewall Evaluation from CyberRatings.org
Apr 3, 2025 08:00AM Cary Street Partners Expands with Acquisition of Keene & Dorchak
Apr 3, 2025 08:00AM Newegg Confirms Effective Date of Share Combination
Apr 3, 2025 08:00AM Stayterra Launched as Premier Vacation Rental Management Collection
Apr 3, 2025 08:00AM LiveRamp Announces Collaboration with Western Union Media Network to Unlock Multicultural Audiences for Advertisers
Apr 3, 2025 08:00AM Lineage to Report First-Quarter 2025 Financial Results on April 30, 2025
Apr 3, 2025 08:00AM Vizgen Announces End of Litigation with 10x Genomics and Harvard University
Apr 3, 2025 08:00AM FIGS Adds Digital Marketing Executive Jerry Jao as New Independent Director to Its Board of Directors
Apr 3, 2025 08:00AM Enterprise Products Partners L.P. 2024 Letter to Investors Now Available
Apr 3, 2025 08:00AM Sallyport Commercial Finance LLC Selects FGI T.R.U.S.T.™ for Credit Insurance Management
Apr 3, 2025 08:00AM BlossomHill Therapeutics to Present the Design and Discovery of BH-30643, the Company’s OMNI-EGFR™ Inhibitor, at the 2025 AACR Annual Meeting
Apr 3, 2025 08:00AM Besitos Announces Leadership Transition, Driving its Mission To Empower Growth and Enhance Financial Well-Being
Apr 3, 2025 08:00AM Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States
Apr 3, 2025 08:00AM A10 Networks to Announce First Quarter 2025 Financial Results on May 1, 2025
Apr 3, 2025 08:00AM Revvity to Hold Earnings Call on Monday, April 28, 2025
Apr 3, 2025 08:00AM PROG Holdings, Inc. to Release First Quarter 2025 Financial Results on April 23, 2025
Apr 3, 2025 08:00AM Identity Fraud Costs Organizations an Average of $7 Million Annually, Says New Research From Docusign and Entrust
Apr 3, 2025 08:00AM Genius Sports' FANHub Platform Powers Award-Winning Indy 500 Marketing Partnership with EchoPoint Media
Apr 3, 2025 08:00AM Terradot Signs 12,000T CDR Deal with Microsoft to Advance Critical Scientific Foundations for Enhanced Rock Weathering
Apr 3, 2025 08:00AM Leading Edge Residential Real Estate Joins Paintzen Partner Program
Apr 3, 2025 08:00AM Student Athlete Score Signs Michigan Athletics to a Multi-Year Deal to Enhance NIL Strategy
Apr 3, 2025 08:00AM K2 Insurance Services Launches K2 Cyber, a Modern MGA for SMB Cyber Insurance
Apr 3, 2025 08:00AM A New Frontier in Radios: Rocket Lab Announces Expanded Radio Products for Reliable Command and Control
Apr 3, 2025 08:00AM Amneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S.
View Newer Stories View Older Stories